tiprankstipranks
Trending News
More News >
Amgen (AMGN)
NASDAQ:AMGN
US Market

Amgen (AMGN) Income Statement

Compare
6,747 Followers

Amgen Income Statement

Last quarter (Q3 2025), Amgen's total revenue was $9.56B, an increase of 12.40% from the same quarter last year. In Q3, Amgen's net income was $3.22B. See Amgen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 33.42B$ 28.19B$ 26.32B$ 25.98B$ 25.42B
Gross Profit
$ 20.57B$ 19.77B$ 19.92B$ 19.52B$ 19.27B
Operating Expenses
$ 13.31B$ 11.84B$ 10.35B$ 11.89B$ 10.13B
Depreciation and Amortization
$ 5.59B$ 4.07B$ 3.42B$ 3.40B$ 3.60B
EBITDA
$ 13.36B$ 14.80B$ 12.17B$ 11.30B$ 13.00B
Operating Income
$ 7.26B$ 7.90B$ 9.57B$ 7.64B$ 9.14B
Other Income/Expenses
$ -2.65B$ -42.00M$ -2.22B$ -938.00M$ -1.01B
Pretax Income
$ 4.61B$ 7.86B$ 7.35B$ 6.70B$ 8.13B
Net Income
$ 4.09B$ 6.72B$ 6.55B$ 5.89B$ 7.26B
Per Share Metrics
Basic EPS
$ 7.56$ 12.56$ 12.18$ 10.34$ 12.40
Diluted EPS
$ 7.56$ 12.49$ 12.11$ 10.28$ 12.31
Weighted Average Shares Outstanding
541.00M 535.00M 538.00M 570.00M 586.00M
Weighted Average Shares Outstanding (Diluted)
541.00M 538.00M 541.00M 573.00M 590.00M
Currency in USD

Amgen Earnings and Revenue History